196 related articles for article (PubMed ID: 20922537)
1. Effects of telmisartan on markers of ventricular remodeling in patients with acute myocardial infarction: comparison with enalapril.
Yokota T; Osanai T; Hanada K; Kushibiki M; Abe N; Oikawa K; Tomita H; Higuma T; Yokoyama J; Hanada H; Okumura K
Heart Vessels; 2010 Nov; 25(6):460-8. PubMed ID: 20922537
[TBL] [Abstract][Full Text] [Related]
2. Impact of telmisartan on coronary stenting in patients with acute myocardial infarction compared with enalapril.
Yokoyama J; Higuma T; Tomita H; Abe N; Oikawa K; Fujiwara T; Yokota T; Yokoyama H; Kimura M; Sasaki S; Hanada H; Osanai T; Okumura K
Int J Cardiol; 2009 Feb; 132(1):114-20. PubMed ID: 18190989
[TBL] [Abstract][Full Text] [Related]
3. Imidapril and enalapril similarly inhibit plasma matrix metalloproteinase activities and attenuate left ventricular remodeling in patients with acute myocardial infarction.
Yokota T; Tomita H; Mori Y; Kudo T; Hiraga H; Suto N; Higuma T; Abe N; Hanada H; Osanai T; Okumura K
J Cardiovasc Pharmacol; 2014 Jun; 63(6):528-32. PubMed ID: 24709636
[TBL] [Abstract][Full Text] [Related]
4. Prospective, randomized, single-blind comparison of effects of 6 months of treatment with telmisartan versus enalapril on high-molecular-weight adiponectin concentrations in patients with coronary artery disease.
Satoh M; Tabuchi T; Minami Y; Takahashi Y; Itoh T; Nakamura M
Clin Ther; 2009 Oct; 31(10):2113-25. PubMed ID: 19922882
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory effect of candesartan cilexetil on left ventricular remodeling after myocardial infarction.
Suzuki H; Kusuyama T; Omori Y; Soda T; Tsunoda F; Sato T; Shoji M; Iso Y; Kondo T; Koba S; Geshi E; Katagiri T
Int Heart J; 2006 Sep; 47(5):715-25. PubMed ID: 17106142
[TBL] [Abstract][Full Text] [Related]
6. Enalapril suppresses ventricular remodeling more effectively than losartan in patients with acute myocardial infarction.
Onodera H; Matsunaga T; Tamura Y; Maeda N; Higuma T; Sasaki S; Mori Y; Yoshimachi F; Ishizaka H; Hanada H; Osanai T; Okumura K
Am Heart J; 2005 Oct; 150(4):689. PubMed ID: 16209966
[TBL] [Abstract][Full Text] [Related]
7. A comparison study of the echocardiographic changes in hypertensive patients treated with telmisartan vs. enalapril.
Hadi NR; Abdulzahra MS; Al-Huseini LM; Al-Aubaidy HA
Int J Cardiol; 2017 Mar; 230():269-274. PubMed ID: 28041700
[TBL] [Abstract][Full Text] [Related]
8. Effects of the replacement of the angiotensin converting enzyme inhibitor enalapril by the angiotensin II receptor blocker telmisartan in patients with congestive heart failure. The replacement of angiotensin converting enzyme inhibition (REPLACE) investigators.
Dunselman PH;
Int J Cardiol; 2001 Feb; 77(2-3):131-8; discussion 139-40. PubMed ID: 11182175
[TBL] [Abstract][Full Text] [Related]
9. Plasma MMP-2, MMP-9 and N-BNP in long-term survivors following complicated myocardial infarction: relation to cardiac magnetic resonance imaging measures of left ventricular structure and function.
Orn S; Manhenke C; Squire IB; Ng L; Anand I; Dickstein K
J Card Fail; 2007 Dec; 13(10):843-9. PubMed ID: 18068618
[TBL] [Abstract][Full Text] [Related]
10. Relationship between myocardial flow reserve by oxygen-15 water positron emission tomography in the subacute phase of myocardial infarction and left ventricular remodeling in the chronic phase.
Ohara M; Yukiiri K; Masugata H; Iwado Y; Takinami H; Nishiyama Y; Ohkawa M; Senda S; Ohmori K; Kohno M
Hypertens Res; 2008 Jul; 31(7):1307-13. PubMed ID: 18957800
[TBL] [Abstract][Full Text] [Related]
11. Prospective evaluation comparing the effects of enalapril and losartan in left ventricular remodeling after acute myocardial infarction.
Maia LN; Nicolau JC; Vítola JV; Santos M; Brandi JM; Joaquim MR; Baggi JM; Cordeiro JA; de Godoy MF
Am Heart J; 2003 Jun; 145(6):E21. PubMed ID: 12796769
[TBL] [Abstract][Full Text] [Related]
12. Different roles of PPAR-γ activity on physiological and pathological alteration after myocardial ischemia.
Nagashima A; Watanabe R; Ogawa M; Suzuki J; Masumura M; Hishikari K; Shimizu T; Takayama K; Hirata Y; Nagai R; Isobe M
J Cardiovasc Pharmacol; 2012 Aug; 60(2):158-64. PubMed ID: 22561360
[TBL] [Abstract][Full Text] [Related]
13. Ventricular and vascular remodelling effects of the angiotensin II receptor blocker telmisartan and/or the angiotensin-converting enzyme inhibitor ramipril in hypertensive patients.
Petrovic I; Petrovic D; Vukovic N; Zivanovic B; Dragicevic J; Vasiljevic Z; Babic R
J Int Med Res; 2005; 33 Suppl 1():39A-49A. PubMed ID: 16222899
[TBL] [Abstract][Full Text] [Related]
14. Telmisartan, an angiotensin-II receptor blocker ameliorates cardiac remodeling in rats with dilated cardiomyopathy.
Sukumaran V; Watanabe K; Veeraveedu PT; Thandavarayan RA; Gurusamy N; Ma M; Yamaguchi K; Suzuki K; Kodama M; Aizawa Y
Hypertens Res; 2010 Jul; 33(7):695-702. PubMed ID: 20535115
[TBL] [Abstract][Full Text] [Related]
15. Telmisartan versus angiotension-converting enzyme inhibitors in the treatment of hypertension: a meta-analysis of randomized controlled trials.
Zou Z; Xi GL; Yuan HB; Zhu QF; Shi XY
J Hum Hypertens; 2009 May; 23(5):339-49. PubMed ID: 18987649
[TBL] [Abstract][Full Text] [Related]
16. Treatment of hypertension with an angiotensin II-receptor antagonist compared with an angiotensin-converting enzyme inhibitor: a review of clinical studies of telmisartan and enalapril.
Smith DH
Clin Ther; 2002 Oct; 24(10):1484-501. PubMed ID: 12462282
[TBL] [Abstract][Full Text] [Related]
17. Effects of telmisartan and enalapril on renoprotection in patients with mild to moderate chronic kidney disease.
Nakamura T; Fujiwara N; Kawagoe Y; Sugaya T; Ueda Y; Koide H
Eur J Clin Invest; 2010 Sep; 40(9):790-6. PubMed ID: 20584070
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin receptor blockade and angiotensin-converting-enzyme inhibition limit adverse remodeling of infarct zone collagens and global diastolic dysfunction during healing after reperfused ST-elevation myocardial infarction.
Jugdutt BI; Idikio H; Uwiera RR
Mol Cell Biochem; 2007 Sep; 303(1-2):27-38. PubMed ID: 17426929
[TBL] [Abstract][Full Text] [Related]
19. Circulating level of gelatinase activity predicts ventricular remodeling in patients with acute myocardial infarction.
Matsunaga T; Abe N; Kameda K; Hagii J; Fujita N; Onodera H; Kamata T; Ishizaka H; Hanada H; Osanai T; Okumura K
Int J Cardiol; 2005 Nov; 105(2):203-8. PubMed ID: 16243114
[TBL] [Abstract][Full Text] [Related]
20. Relationship between transcardiac extraction of aldosterone and left ventricular remodeling in patients with first acute myocardial infarction: extracting aldosterone through the heart promotes ventricular remodeling after acute myocardial infarction.
Hayashi M; Tsutamoto T; Wada A; Maeda K; Mabuchi N; Tsutsui T; Matsui T; Fujii M; Matsumoto T; Yamamoto T; Horie H; Ohnishi M; Kinoshita M
J Am Coll Cardiol; 2001 Nov; 38(5):1375-82. PubMed ID: 11691511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
